Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2021 4
2022 4
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Immune-mediated liver injury following COVID-19 vaccination.
Schinas G, Polyzou E, Dimakopoulou V, Tsoupra S, Gogos C, Akinosoglou K. Schinas G, et al. Among authors: dimakopoulou v. World J Virol. 2023 Mar 25;12(2):100-108. doi: 10.5501/wjv.v12.i2.100. World J Virol. 2023. PMID: 37033146 Free PMC article. Review.
Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.
Akinosoglou K, Savopoulos C, Pouliakis A, Triantafyllidis C, Markatis E, Golemi F, Liontos A, Vadala C, Papanikolaou IC, Dimakopoulou V, Xarras P, Varela K, Kaiafa G, Mitsianis A, Chatzistamati A, Randou E, Savvanis S, Pavlaki M, Efraimidis G, Samaras V, Papazoglou D, Konstantinidou A, Panagopoulos P, Milionis H, On Behalf Of The Interact Study Group. Akinosoglou K, et al. Among authors: dimakopoulou v. Viruses. 2022 Apr 7;14(4):767. doi: 10.3390/v14040767. Viruses. 2022. PMID: 35458497 Free PMC article.
ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients.
Karakike E, Dalekos GN, Koutsodimitropoulos I, Saridaki M, Pourzitaki C, Papathanakos G, Kotsaki A, Chalvatzis S, Dimakopoulou V, Vechlidis N, Paramythiotou E, Avgoustou C, Ioakeimidou A, Kouriannidi E, Komnos A, Neou E, Rovina N, Stefanatou E, Milionis H, Nikolaidis G, Koutsoukou A, Damoraki G, Dimopoulos G, Zoumpos V, Eugen-Olsen J, Akinosoglou K, Gatselis NK, Koulouras V, Gkeka E, Markou N, Netea MG, Giamarellos-Bourboulis EJ. Karakike E, et al. Among authors: dimakopoulou v. J Innate Immun. 2022;14(3):218-228. doi: 10.1159/000519090. Epub 2021 Dec 1. J Innate Immun. 2022. PMID: 34852352 Free PMC article.
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study.
Akinosoglou K, Schinas G, Bletsa E, Bristianou M, Lanaras L, Michailides C, Katsikas T, Barkas F, Liberopoulos E, Kotsis V, Tentolouris K, Grigoropoulou P, Frangou A, Basoulis D, Alexiou Z, Daganou M, Bostantzoglou C, Dimakopoulou V, Koutsoukou A, Pefanis A, Baraboutis IG, Agelonidou E, Tentolouris N. Akinosoglou K, et al. Among authors: dimakopoulou v. Microorganisms. 2023 May 27;11(6):1416. doi: 10.3390/microorganisms11061416. Microorganisms. 2023. PMID: 37374918 Free PMC article.
Radiologic Features of T10 Paravertebral Muscle Sarcopenia: Prognostic Factors in COVID-19.
Schinas G, Dimakopoulou V, Dionysopoulos K, Fezoulidi G, Vlychou M, Vassiou K, Gatselis NK, Samakidou A, Giannoulis G, Tzouvelekis A, Marangos M, Gogos C, Dalekos GN, Kalogeropoulou C, Akinosoglou K. Schinas G, et al. Among authors: dimakopoulou v. J Clin Med Res. 2023 Jul;15(7):368-376. doi: 10.14740/jocmr4963. Epub 2023 Jul 31. J Clin Med Res. 2023. PMID: 37575354 Free PMC article.
Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia.
Petrakis V, Rapti V, Akinosoglou K, Bonelis C, Athanasiou K, Dimakopoulou V, Syrigos NK, Spernovasilis N, Trypsianis G, Marangos M, Gogos C, Papazoglou D, Panagopoulos P, Poulakou G. Petrakis V, et al. Among authors: dimakopoulou v. Microorganisms. 2022 Sep 30;10(10):1949. doi: 10.3390/microorganisms10101949. Microorganisms. 2022. PMID: 36296225 Free PMC article.
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)-Analysis of Data from Daily Practice.
Pantazis N, Pechlivanidou E, Antoniadou A, Akinosoglou K, Kalomenidis I, Poulakou G, Milionis H, Panagopoulos P, Marangos M, Katsarolis I, Kazakou P, Dimakopoulou V, Chaliasou AL, Rapti V, Christaki E, Liontos A, Petrakis V, Schinas G, Biros D, Rimpa MC, Touloumi G. Pantazis N, et al. Among authors: dimakopoulou v. Microorganisms. 2023 Aug 3;11(8):1998. doi: 10.3390/microorganisms11081998. Microorganisms. 2023. PMID: 37630558 Free PMC article.
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study.
Karampitsakos T, Malakounidou E, Papaioannou O, Dimakopoulou V, Zarkadi E, Katsaras M, Tsiri P, Tsirikos G, Georgiopoulou V, Oikonomou I, Davoulos C, Velissaris D, Sampsonas F, Marangos M, Akinosoglou K, Tzouvelekis A. Karampitsakos T, et al. Among authors: dimakopoulou v. Respir Res. 2021 Dec 22;22(1):317. doi: 10.1186/s12931-021-01914-6. Respir Res. 2021. PMID: 34937570 Free PMC article.
Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells.
Nikitopoulou I, Fanidis D, Ntatsoulis K, Moulos P, Mpekoulis G, Evangelidou M, Vassiliou AG, Dimakopoulou V, Jahaj E, Tsipilis S, Orfanos SE, Dimopoulou I, Angelakis E, Akinosoglou K, Vassilaki N, Tzouvelekis A, Kotanidou A, Aidinis V. Nikitopoulou I, et al. Among authors: dimakopoulou v. Int J Mol Sci. 2021 Sep 16;22(18):10006. doi: 10.3390/ijms221810006. Int J Mol Sci. 2021. PMID: 34576169 Free PMC article.
11 results